China National Biotec Group Company Limited | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.	DNA Virus Infections, Infections, cowpox, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease	Recruiting	Phase 1	2026-01-29		NCT07377175
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines	Digestive System Diseases, Infections, Mononegavirales infectious disease, Neuroinflammatory Diseases, Paramyxoviridae infectious disease, Picornaviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, myelitis, nervous system disorder, neuromuscular disease, parotid disorder, parotitis, poliomyelitis, rubella, salivary gland disorder, spinal cord disorder, viral hepatitis, viral infectious disease	Not yet recruiting	Not stated	2026-01-14		NCT07338851
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus	Active, not recruiting	Phase 3	2025-09-15		NCT05091619